News
12-10-2010, 09:10 AM
The long-awaited results of the Adjuvant Treatment with Zoledronic Acid in Stage II/III Breast Cancer, the AZURE trial, will be presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held here Dec. 8-12...
More... (http://mnt.to/f/3NSQ)
More... (http://mnt.to/f/3NSQ)